Golden Minerals Co (AUMN): Nasdaq/NYSE listing notice — Golden Minerals receives NYSE American plan acceptance to regain listing compliance by Dec 2024

Golden Minerals Co

NYSE American accepted compliance plan on Aug 22, 2023; company had equity of $4.1M (Mar 31) and $5.6M (Jun 30) vs $6M minimum.
Cure period granted until December 6, 2024 to satisfy Section 1003(a)(iii) of the NYSE American Company Guide.
Common stock (AUMN) will continue trading on NYSE American under periodic monitoring during the plan period.
Failure to make progress consistent with the plan or to regain compliance by Dec 2024 may result in delisting.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Golden Minerals Co received a nyse_american deficiency notice notice regarding stockholders equity (rules 1003(a)(iii)).

Exchange: nyse american
Notice: deficiency notice
Deficiency: stockholders equity
Rules: 1003(a)(iii)

Exact text from the filing

June 6, 2023 that the Company is not in compliance with Section 1003(a)(iii) of the NYSE American Company Guide (the “Company Guide”). The Company is required to report a stockholders’ equity of $6.0 million or more if the Company has reported losses from continuing operations and/or net losses in its five most recent fiscal years. The Company reported stockholders’ equity of $4.1 million as of March 31, 2023, and $5.6 million as of June 30, 2023, and losses from continuing operations and/or net losses in each of its five most recent fiscal years ended December 31, 2022. As a result, the Compa

View on SEC.gov

Browse all listing & compliance notices →

Golden Minerals Co filing history →

Source: SEC EDGAR

accession 0001104659-23-094938

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.